Literature DB >> 7811147

[Patent foramen ovale: an anatomical study. Apropos of 500 consecutive autopsies].

P Penther1.   

Abstract

A patent foramen ovale (PFO) was looked for in 500 consecutive adult autopsy studies (265 men, 235 women) in which death was due to acquired cardiovascular pathology (mainly coronary artery disease); this condition was demonstrated in 73 cases (42 men, 31 women); 14.6%. A PFO forms a short inter-atrial communication (average length 5 mm) directed anteriorly and slightly superiorly, opening in the right atrium anteriorly at the junction of the fosse ovale-limbus and in the left atrium under membranous fold concave anteriorly, which represents the anterior expansion of the valve of the fosse ovale. The average surface area of the PFO is 0.5 cm2 (range 0.2 to 1.5 cm2). The underlying cardiac pathologies, age, sex, had no relation to the frequency of PFO. Of the different analysable anatomical features, weight of the heart, atrial size, tricuspid regurgitation, texture of the fosse ovale (thickness over 1mm, or thin, transparent membrane), dimensions of the Eustachian valve, had no influence on the frequency of PFO. No thromboses were observed incarcerated in, in contact with or adherent to the right atrial surface of the PFO. Three of the 73 patients with PFO had, shortly before death, experienced an embolic cerebrovascular accident: in all 3 cases there was a thrombus in the left heart chambers.

Entities:  

Mesh:

Year:  1994        PMID: 7811147

Source DB:  PubMed          Journal:  Arch Mal Coeur Vaiss        ISSN: 0003-9683


  11 in total

Review 1.  Patent foramen ovale and stroke.

Authors:  Shunichi Homma; Marco R Di Tullio
Journal:  J Cardiol       Date:  2010-06-29       Impact factor: 3.159

Review 2.  Risk Factors for Ischemic Stroke in Younger Adults: A Focused Update.

Authors:  Mary G George
Journal:  Stroke       Date:  2020-02-12       Impact factor: 7.914

Review 3.  [Interventional closure of atrial septal defects, patent oval foramen and ventricular septal defects].

Authors:  Marius Hornung; Jennifer Franke; Dani Id; Horst Sievert
Journal:  Herz       Date:  2015-08       Impact factor: 1.443

4.  PFO and right-to-left shunting in patients with obstructive sleep apnea.

Authors:  Marina Guchlerner; Peter Kardos; Eva Liss-Koch; Jennifer Franke; Nina Wunderlich; Stefan Bertog; Horst Sievert
Journal:  J Clin Sleep Med       Date:  2012-08-15       Impact factor: 4.062

Review 5.  Patent foramen ovale and stroke: what should be done?

Authors:  Marco R Di Tullio; Shunichi Homma
Journal:  Curr Opin Hematol       Date:  2009-09       Impact factor: 3.284

Review 6.  Correlation or causation: untangling the relationship between patent foramen ovale and migraine.

Authors:  Eric Adler; Barry Love; Steve Giovannone; Frank Volpicelli; Martin E Goldman
Journal:  Curr Cardiol Rep       Date:  2007-03       Impact factor: 2.931

7.  Central venous line and acute neurological deficit: a case series.

Authors:  Seyed Hossein Ahmadi; Mahmood Shirzad; Sam Zeraatian; Abbas Salehiomran; Seyed Hesameddin Abbasi; Atefeh Ghiasi
Journal:  J Tehran Heart Cent       Date:  2014-07-06

8.  Statement on Antiplatelet Agents and Anticoagulants in Cardiology - 2019.

Authors:  Carlos V Serrano; Alexandre de M Soeiro; Tatiana C A Torres Leal; Lucas C Godoy; Bruno Biselli; Luiz Akira Hata; Eduardo B Martins; Isabela C K Abud-Manta; Caio A M Tavares; Francisco Akira Malta Cardozo; Múcio Tavares de Oliveira
Journal:  Arq Bras Cardiol       Date:  2019-08-08       Impact factor: 2.000

9.  Unusual cause of hypoxemia after automatic implantable cardioverter-defibrillatorleads extraction.

Authors:  Dinesh Raju; Chandrika Roysam; Rajendra Singh; Stephen C Clark; Christopher Plummer
Journal:  Ann Card Anaesth       Date:  2015 Oct-Dec

Review 10.  Epidemiology of Patent Foramen Ovale in General Population and in Stroke Patients: A Narrative Review.

Authors:  Ioanna Koutroulou; Georgios Tsivgoulis; Dimitrios Tsalikakis; Dimitris Karacostas; Nikolaos Grigoriadis; Theodoros Karapanayiotides
Journal:  Front Neurol       Date:  2020-04-28       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.